Hormone Health Data and Research Act directs NIH and USPSTF to study hormone variability and testing in women with perimenopause.
The Hormone Health Data and Research Act mandates the Director of the National Institutes of Health to assess evidence on hormone level variability in women before perimenopause symptoms appear. It also requires the United States Preventive Services Task Force to review evidence on the clinical utility of hormone testing in diagnosing or managing perimenopause. Within 18 months of enactment, both NIH and USPSTF must submit a report to specified congressional committees summarizing findings, identifying evidence gaps, and recommending future research or clinical guidance.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.